This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)
Review
Practical aspects of treatment with drotrecogin alfa (activated)
-
* Corresponding author: Duncan Wyncoll duncan.wyncoll@gstt.nhs.uk
Critical Care 2007, 11(Suppl 5):S7 doi:10.1186/cc6158
No comments have yet been made on this article.